{
  "publication": {
    "title": "A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHL",
    "author": "Staiger et al.",
    "year": 2019,
    "doi": "https://doi.org/10.1038/s41375-019-0573-y",
    "pubmed id": ""
  },
  "data": {
    "website": "https://gitlab.spang-lab.de/sct39258/toscdata",
    "disease type": "DLBCL",
    "number of samples": 466,
    "pheno data": {
      "included in survival analysis": 466,
      "pivot time cutoff": 2,
      "number high risk": 104,
      "number low risk": 324,
      "unknown": 38,
      "proportion high risk": 0.243
    },
    "expression data": {
      "technology": "NanoString",
      "platform": "nCounter",
      "read length": "",
      "number of genes": 144,
      "gene symbols": "HGNC",
      "primary processing": "",
      "normalization": "log2"
    },
    "benchmark": {
      "name": "ipi",
      "reference": "",
      "performance": {
        "ipi >=": [5, 4, 3, 2, 1],
        "rpp": [0.034, 0.1698, 0.4259, 0.6821, 1],
        "prec": [0.4545, 0.3818, 0.3696, 0.3167, 0.2407]
      }
    }
  }
}
